Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
1.970
-0.020 (-1.01%)
At close: Nov 7, 2024, 4:00 PM
1.870
-0.100 (-5.08%)
After-hours: Nov 7, 2024, 6:04 PM EST
Accelerate Diagnostics Employees
Accelerate Diagnostics had 134 employees as of December 31, 2023. The number of employees decreased by 45 or -25.14% compared to the previous year.
Employees
134
Change (1Y)
-45
Growth (1Y)
-25.14%
Revenue / Employee
$91,291
Profits / Employee
-$282,881
Market Cap
46.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Allurion Technologies | 504 |
HOOKIPA Pharma | 179 |
Vicarious Surgical | 131 |
Carisma Therapeutics | 107 |
OncoCyte | 46 |
Unicycive Therapeutics | 14 |
CalciMedica | 12 |
VYNE Therapeutics | 10 |
AXDX News
- 5 hours ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 13 days ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 5 weeks ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire
- 3 months ago - Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Accelerate Diagnostics Reports Second Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial - PRNewsWire
- 3 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results - PRNewsWire
- 6 months ago - Accelerate Diagnostics, Inc. (AXDX) Q1 2024 Earnings Call Transcript - Seeking Alpha